Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users (Q43752658)

26 November 2017

Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users (English)

1 reference

26 November 2017

Loughlin A

1

1 reference

26 November 2017

Metsch L

2

1 reference

26 November 2017

Gardner L

3

1 reference

26 November 2017

Anderson-Mahoney P

4

1 reference

26 November 2017

Barrigan M

5

1 reference

26 November 2017

Strathdee S

6

1 reference

26 November 2017

1 May 2004

1 reference

26 November 2017

1 reference

26 November 2017

16

1 reference

26 November 2017

4

1 reference

26 November 2017

485-500

1 reference

Trust and the acceptance of and adherence to antiretroviral therapy

26 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Management of psychiatric disorders in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Helping the urban poor stay with antiretroviral HIV drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

When should we delay highly active antiretroviral therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Expanding directly observed therapy: tuberculosis to human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Use of mental health and substance abuse treatment services among adults with HIV in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Self-reported antiretroviral therapy in injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Race, sex, drug use, and progression of human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Antiretroviral therapy for drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Delays in protease inhibitor use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Combination antiretroviral therapy: health care providers confront emerging dilemmas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

HIV infection in women in the United States: status at the Millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Hospital and outpatient health services utilization among HIV-infected patients in care in 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Prevalence and predictors of unmet need for supportive services among HIV-infected persons: impact of case management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Access to medical care and service utilization among injection drug users with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Use of Antiretroviral Therapy by Intravenous Drug Users With HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Modified directly observed therapy for treatment of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Medical care for injection-drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Drug abuse, methadone treatment, and health services use among injection drug users with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Trillion virion delay: time from testing positive for HIV to presentation for primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Barriers to use of free antiretroviral therapy in injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001683411

10.1080/09540120410001683411

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference